Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, Following Oral Administration of Single Doses to HIV-Infected Adults

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.43.7.1686
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Safety and Pharmacokinetics of Abacavir (1592U89) Following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1999English

Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor

Journal of Clinical Microbiology
Microbiology
1999English

Single-Dose Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Type 1 Protease Inhibitor, in Subjects With Normal or Impaired Hepatic Function

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Intracellular Expression of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Variants Inhibits Replication of Wild-Type and Protease Inhibitor-Resistant HIV-1 Strains in Human T-Cell Lines.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1996English

Crystal Structure of Human Immunodeficiency Virus (HIV) Type 2 Protease in Complex With a Reduced Amide Inhibitor and Comparison With HIV-1 Protease Structures.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1993English

Interactions of Single and Combined Human Immunodeficiency Virus Type 1 (HIV-1) DNA Vaccines

Virology
Virology
2001English

Activities of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor Nelfinavir Mesylate in Combination With Reverse Transcriptase and Protease Inhibitors Against Acute HIV-1 Infection in Vitro.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Defining the Level of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Activity Required for HIV-1 Particle Maturation and Infectivity.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1995English

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy